Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The present study examined the role of the cytokine IL-6 in the regulation of fatty acid metabolism during exercise in humans. Six well-trained males completed three trials of 120 min of cycle ergometry at 70% peak O 2 consumption (V̇o 2 peak; MOD) and 40% V̇o 2 peak with (LOW + IL-6) and without (LOW) infusion of recombinant human (rh)IL-6. The dose of rhIL-6 during LOW + IL-6 elicited IL-6 concentration similar to those during MOD but without altering the circulating hormonal milieu seen in MOD. Palmitate rate of appearance (R a), rate of disappearance (R d), and oxidation were measured by means of a constant infusion of [U-13 C]palmitate (0.015 μmol·kg−1·min−1, prime NaHCO 3, 1 μmol/kg). Palmitate R a, R d, and oxidation were not affected by rhIL-6 infusion, remaining similar to LOW at all times. Palmitate R a and oxidation were significantly greater in the MOD trial ( P < 0.05) compared with the LOW + IL-6 and LOW trials. Our data show that a low dose of rhIL-6, administered during low-intensity exercise without altering the hormonal milieu, does not alter fatty acid metabolism. These data suggest that the increase in fatty acid utilization seen during exercise at moderate compared with low intensity is not mediated via alterations in plasma IL-6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 1×
“IL-6deficient mice develop mature-onset obesity within 9 mo of age, which is reversed by 18 days of intraperitoneal IL-6 treatment (24), whereas rats fed a high-fat diet display a decreased body fat content following 2 wk of daily IL-6 injections, not shown in saline-treated, control rats (25).”
BackgroundSteensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095
Self-citationMuscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875 · cited 1×
“Work from our laboratories has focused on the IL-6 response within skeletal muscle and its influence on metabolic processes (4).”
BackgroundSelf-citationInterleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767 · cited 7×
“In our previous study in healthy males at rest (23) and recent work from our laboratory in both elderly and type 2 diabetes patients (27), rhIL-6 infusion induced an increase in circulating cortisol level.”
BackgroundResultSelf-citationEvidence that interleukin-6 is produced in human skeletal muscle during prolonged running
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.949bp.x · Cited by 673 · cited 1×
“Plasma IL-6 concentration typically increases at a much slower rate, and even prolonged exhaustive exercise, such as a marathon (13, 17), usually elicits far lower circulating plasma IL-6 concentrations than those reported in previous rhIL-6 infusion studies.”
BackgroundSelf-citationPetersen, E. W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2004 · Cited by 311
Self-citationTsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P. (2008) · Neuroendocrinology · doi:10.1159/000127219 · Cited by 223 · cited 1×
“Growth hormone has been shown to be increased in some (21), but not all (16), rhIL-6 infusion studies and is known to be a strong regulator of lipolysis (12).”
BackgroundEffects of a growth hormone pulse on total and forearm substrate fluxes in humans
Moller, N., Jorgensen, J. O., Schmitz, O., Moller, J., Christiansen, J., Alberti, K. G., & Orskov, H. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e86 · Cited by 194
Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans
Djurhuus, C. B., Gravholt, C. H., Nielsen, S., Pedersen, S. B., Møller, N., & Schmitz, O. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00199.2003 · Cited by 131 · cited 1×
“Glucocorticoids have been shown to both increase lipolysis in vivo (3) and decrease lipolysis in vivo and in cultured adipocytes (7, 14) and are considered less powerful regulators of lipolysis.”
BackgroundEffects of Cortisol and Growth Hormone on Lipolysis in Human Adipose Tissue
Ottosson, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.799 · Cited by 64
Research works printed but not linked: 16
- 10.1016/S0065-2776(08)60532-5 · DOI · Paper page
- 10.1152/ajpendo.1997.272.6.E1130 · DOI
- 10.1096/fj.03-1259fje · DOI · Paper page
- 10.1152/japplphysiol.00195.2004 · DOI · Paper page
- 10.2337/diab.40.1.141 · DOI · Paper page
- 10.1210/jc.2003-030703 · DOI
- 10.1046/j.1365-201X.2003.01167.x · DOI
- 10.1113/jphysiol.2002.021022 · DOI · Paper page
- Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, and Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196–4200, 1997. · DOI · Paper page
- 10.1096/fj.03-0311fje · DOI · Paper page
- Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, and Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83: 1573–1579, 1998. · DOI · Paper page
- 10.1152/ajpcell.2001.280.4.C769 · DOI · Paper page
- 10.1111/j.1749-6632.1959.tb44923.x · DOI · Paper page
- 10.1152/ajpendo.1995.268.5.E813 · DOI · Paper page
- 10.1113/jphysiol.2002.023796 · DOI · Paper page
- 10.1016/S0006-291X(02)00230-9 · DOI · Paper page
Cited by
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Self-citationInterleukin-6 in acute exercise and training: what is the biological relevance?
Fischer, C. P. (2026) · PubMed · doi:10.22029/eir.2006.1620 · Cited by 825
Self-citationRegulation of adipocyte lipolysis
Frühbeck, G., Méndez-Giménez, L., Fernández-Formoso, J.-A., Fernández, S., & Rodríguez, A. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400002x · Cited by 429
Physical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology
Thompson, D., Karpe, F., Lafontan, M., & Frayn, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00012.2011 · Cited by 402
McKay, B. R., De Lisio, M., Johnston, A. P. W., O'Reilly, C. E., Phillips, S. M., Tarnopolsky, M. A., & Parise, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006027 · Cited by 149
“short duration exercise [42–45].”
Metadata
- Authors
- Hiscock, N., Fischer, C. P., Sacchetti, M., van Hall, G., Febbraio, M. A., & Pedersen, B. K.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2005-07
- Volume
- 289
- Issue
- 1
- Pages
- E2-E7
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2116902014
- Cited by
- 30
- References
- 10
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.